- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01388010
Study of the Effect of a Fermented Dairy Product on Gastrointestinal Well Being in Adult Women
October 26, 2016 updated by: Danone Research
"Effect of the Consumption of a Fermented Dairy Product on Gastrointestinal Well-being in a Healthy Population of Women With Minor Digestive Symptoms"
The purpose of this study is to evaluate the effect of a commercially available fermented dairy product containing probiotics (4 weeks, twice a day) on the improvement of gastrointestinal well being and digestive symptoms in adult women reporting minor digestive troubles among the general population.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
336
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Caen, France, 14052
- RPS Research France
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Female free-living subject aged from 18 to 60 years.
- Subject with a body mass index between 18 and 30.
- Subject with minor digestive symptoms as defined by screening questionnaire of frequency of digestive symptoms.
- Subject with normal stool frequency
Exclusion Criteria:
- Subject with a diagnosis of Irritable Bowel Syndrome (IBS) or other functional bowel disease (constipation, diarrhoea…)
- Subject with known organic disease, including an inflammatory bowel disease, a benign or malign tumour of intestine or colon and significant systemic disease
- Subject under prescription for medication for digestive symptoms such as anti-spasmodic, laxatives and anti-diarrheic drugs
- Subject having taken antibiotics in the last 4 weeks
- Pregnant subject or subject planning to become pregnant during the study; breast-feeding subject.
- Subject with known lactose intolerance or immunodeficiency
- Subject with known allergy to product component (milk protein for example)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1 = Test product
Arm 1 - Intervention 1 (probiotics)
|
|
|
Other: 2 = Control product
Arm 2 - Intervention 2 (control)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (Actual)
December 1, 2009
Study Completion (Actual)
October 1, 2010
Study Registration Dates
First Submitted
July 3, 2011
First Submitted That Met QC Criteria
July 5, 2011
First Posted (Estimate)
July 6, 2011
Study Record Updates
Last Update Posted (Estimate)
October 27, 2016
Last Update Submitted That Met QC Criteria
October 26, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- NU325
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Adult Women
-
Danone ResearchCompletedHealthy Adult WomenUnited States
-
Poznan University of Life SciencesCompletedHealthy Volunteers | Young Adult | WomenPoland
-
TakedaCompleted
-
Perelel Inc.CompletedHealthy Adult Women of Child Bearing AgeIreland
-
Izmir University of EconomicsDokuz Eylul UniversityRecruitingPelvic Floor Muscle Training | Healthy Adult Women | Pelvic Floor Muscle ExerciseTurkey (Türkiye)
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Cairo UniversityNot yet recruitingHealthy Adult Women
-
University of ÉvoraActive, not recruiting
-
Near East University, TurkeyCompletedHealthy Postmenopausal Women | Serum CNP Levels | Healthy Reproductive Age Women | Healthy Perimenopausal WomenCyprus
-
Rousselot BVBABioTeSys GmbHCompleted
Clinical Trials on 1-Fermented Probiotic Dairy Product (test)
-
Danone ResearchCompletedHealthy Free-living ElderlyBelgium
-
Danone ResearchCompletedHealthy Adult WomenUnited States
-
Danone ResearchCompleted
-
Cairo UniversityCompleted
-
Danone ResearchCompletedHealthyBelgium, France, Spain, United Kingdom
-
Danone JapanCompleted
-
Danone ResearchCompleted
-
Danone ResearchCompletedCommon Infectious DiseasesRussian Federation
-
Danone ResearchTerminatedGastroenteritis | Sinusitis | Otitis | Bronchitis | Upper Respiratory Tract Infections | Sore Throat | Flu | Lower Respiratory Tract Infections | Rhinopharyngitis | Pneumopathy | Flu-like SyndromesFrance
-
Danone JapanCompletedSubjects With High LDL-CholesterolJapan